191 related articles for article (PubMed ID: 35912197)
41. Clinicopathological Significance of Micropapillary Pattern in Lung Adenocarcinoma.
Pyo JS; Kim JH
Pathol Oncol Res; 2018 Jul; 24(3):547-555. PubMed ID: 28685219
[TBL] [Abstract][Full Text] [Related]
42. [A nomogram for predicting lymph node metastasis in early gastric cancer].
Cui H; Cao B; Deng H; Liu GB; Liang WQ; Xie TY; Ye L; Zhang QP; Wang N; Liu FD; Wei B
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jan; 25(1):40-47. PubMed ID: 35067033
[No Abstract] [Full Text] [Related]
43. Is there significance in identification of non-predominant micropapillary or solid components in early-stage lung adenocarcinoma?
Zhao ZR; To KF; Mok TS; Ng CS
Interact Cardiovasc Thorac Surg; 2017 Jan; 24(1):121-125. PubMed ID: 27600912
[TBL] [Abstract][Full Text] [Related]
44. Lymph node involvement according to lung adenocarcinoma subtypes: lymph node involvement is influenced by lung adenocarcinoma subtypes.
Park JK; Kim JJ; Moon SW; Lee KY
J Thorac Dis; 2017 Oct; 9(10):3903-3910. PubMed ID: 29268400
[TBL] [Abstract][Full Text] [Related]
45. Prognostic factors of resectable anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer (NSCLC) patients: a retrospective analysis based on a single center.
Zeng A; Xiong Y; Zhang J; Yu H; Zhang L; Bian D; Han L; Wang J; Chen Y; Shaik MS; Zhang P; Dai J
Transl Lung Cancer Res; 2024 Jan; 13(1):16-33. PubMed ID: 38405002
[TBL] [Abstract][Full Text] [Related]
46. EEF1A2 and ERN2 could potentially discriminate metastatic status of mediastinal lymph node in lung adenocarcinomas harboring EGFR 19Del/L858R mutations.
Xia L; Wang H; Xiao H; Lan B; Liu J; Yang Z
Thorac Cancer; 2020 Oct; 11(10):2755-2766. PubMed ID: 32881299
[TBL] [Abstract][Full Text] [Related]
47. High-grade lung adenocarcinomas with micropapillary and/or solid patterns: a review.
Morales-Oyarvide V; Mino-Kenudson M
Curr Opin Pulm Med; 2014 Jul; 20(4):317-23. PubMed ID: 24852329
[TBL] [Abstract][Full Text] [Related]
48. Risk profiles and a concise prediction model for lymph node metastasis in patients with lung adenocarcinoma.
Liang S; Huang YY; Liu X; Wu LL; Hu Y; Ma G
J Cardiothorac Surg; 2023 Jun; 18(1):195. PubMed ID: 37340322
[TBL] [Abstract][Full Text] [Related]
49. Lymph node metastasis in clinical stage IA peripheral lung cancer.
Wang L; Jiang W; Zhan C; Shi Y; Zhang Y; Lin Z; Yuan Y; Wang Q
Lung Cancer; 2015 Oct; 90(1):41-6. PubMed ID: 26212683
[TBL] [Abstract][Full Text] [Related]
50. Prognostic impact of micropapillary and solid histological subtype on patients undergoing curative resection for stage I lung adenocarcinoma according to the extent of pulmonary resection and lymph node assessment.
Jeon YJ; Lee J; Shin S; Cho JH; Choi YS; Kim J; Zo JI; Shim YM; Choi YL; Kim HK
Lung Cancer; 2022 Jun; 168():21-29. PubMed ID: 35462111
[TBL] [Abstract][Full Text] [Related]
51. Dysfunction of CD8
Li C; Hu M; Cai S; Yang G; Yang L; Jing H; Xing L; Sun X
Cancer Sci; 2024 May; ():. PubMed ID: 38720474
[TBL] [Abstract][Full Text] [Related]
52. A Clinicopathological Study of Small Lung Adenocarcinoma 1 cm or Less in Size: Emphasis on Histological Subtypes Associated With Lymph Node Metastasis and Recurrence.
Zhao W; Wang H; Xie J; Tian B
Int J Surg Pathol; 2018 Feb; 26(1):4-11. PubMed ID: 28805108
[TBL] [Abstract][Full Text] [Related]
53. A prognostic nomogram based on a new classification of combined micropapillary and solid components for stage IA invasive lung adenocarcinoma.
Huang W; Zhang H; Zhang Z; Zhang B; Sun X; Huo Y; Feng Y; Tian P; Mo H; Wang C
J Surg Oncol; 2022 Mar; 125(4):796-808. PubMed ID: 34862621
[TBL] [Abstract][Full Text] [Related]
54. The prognostic impact of occult lymph node metastasis in node-negative gastric cancer: a systematic review and meta-analysis.
Huang JY; Xu YY; Li M; Sun Z; Zhu Z; Song YX; Miao ZF; Wu JH; Xu HM
Ann Surg Oncol; 2013 Nov; 20(12):3927-34. PubMed ID: 23892524
[TBL] [Abstract][Full Text] [Related]
55. Micropapillary Predominance Is a Risk Factor for Brain Metastasis in Resected Lung Adenocarcinoma.
Shigenobu T; Takahashi Y; Masugi Y; Hanawa R; Matsushita H; Tajima A; Kuroda H
Clin Lung Cancer; 2021 Nov; 22(6):e820-e828. PubMed ID: 33992533
[TBL] [Abstract][Full Text] [Related]
56. Individualized nomogram for predicting ALK rearrangement status in lung adenocarcinoma patients.
Song L; Zhu Z; Wu H; Han W; Cheng X; Li J; Du H; Lei J; Sui X; Song W; Jin ZY
Eur Radiol; 2021 Apr; 31(4):2034-2047. PubMed ID: 33146791
[TBL] [Abstract][Full Text] [Related]
57. A retrospective study of the relationship between the pathologic subtype and lymph node metastasis of lung adenocarcinomas of ≤3 cm diameter.
Lin W; Huang M; Zhang Z; Chai T; Chen S; Gao L; Lin J; Kang M
Medicine (Baltimore); 2020 Sep; 99(36):e21453. PubMed ID: 32898994
[TBL] [Abstract][Full Text] [Related]
58. Novel method for rapid identification of micropapillary or solid components in early-stage lung adenocarcinoma.
Zhao ZR; Lau RWH; Long H; Mok TSK; Chen GG; Underwood MJ; Ng CSH
J Thorac Cardiovasc Surg; 2018 Dec; 156(6):2310-2318.e2. PubMed ID: 30180981
[TBL] [Abstract][Full Text] [Related]
59. Risk Factors for Occult Lymph Node Metastasis in Peripheral Non-Small Cell Lung Cancer with Invasive Component Size 3 cm or Less.
Moon Y; Choi SY; Park JK; Lee KY
World J Surg; 2020 May; 44(5):1658-1665. PubMed ID: 31912252
[TBL] [Abstract][Full Text] [Related]
60. Micropapillary histological subtype in lung adenocarcinoma of 2 cm or less: impact on recurrence and clinical predictors.
Yoshida Y; Nitadori JI; Shinozaki-Ushiku A; Sato J; Miyaji T; Yamaguchi T; Fukayama M; Nakajima J
Gen Thorac Cardiovasc Surg; 2017 May; 65(5):273-279. PubMed ID: 28243892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
